logo

For the Inventor, By the Inventor

London, United Kingdom

Egalet Ltd.


USPTO Granted Patents = 22

% Expired Patents = 95.5



Forward Citations = 221

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Christine Andersen (11 out of 11 patents)

silverMedal Gina Engslev Fischer (11 out of 14 patents)

bronzeMedal Daniel K Bar-Shalom (11 out of 28 patents)

4.  Lillian Slot (9 out of 12 patents)

5.  Peter Holm Tygesen (8 out of 8 patents)

6.  Jan Martin Oevergaard (8 out of 8 patents)

7.  Karsten Lindhardt (8 out of 12 patents)

8.  Martin Rex Olsen (8 out of 10 patents)

9.  Louise Inoka Lyhne-Iversen (6 out of 6 patents)

10.  Anne-Mette Haahr (6 out of 6 patents)

11.  Pernille Kristine Hoeyrup Hemmingsen (5 out of 5 patents)

12.  Anne-Marie Lademann (3 out of 4 patents)

13.  Nikolaj Skak (2 out of 11 patents)

14.  Jacob Aas Hoeilund-Jensen (2 out of 2 patents)

15.  Pernille Hoyrup Hemmingsen (2 out of 2 patents)


22 patents:

1. 10105321 - Pharmaceutical compositions resistant to abuse (2018-10-23),
2. 9884029 - Morphine controlled release system (2018-02-06),
3. 9707179 - Opioid polymer release system (2017-07-18),
4. 9694080 - Polymer release system (2017-07-04),
5. 9642809 - Controlled release pharmaceutical compositions for prolonged effect (2017-05-09),
6. 9549899 - Abuse deterrent pharmaceutical compositions for controlled release (2017-01-24),
7. 9498446 - Pharmaceutical compositions resistant to abuse (2016-11-22),
8. 9375428 - Morphine controlled release system (2016-06-28),
9. 9358295 - Immediate release composition resistant to abuse by intake of alcohol (2016-06-07),
10. 9168228 - Pharmaceutical compositions resistant to abuse (2015-10-27),
11. 9044402 - Abuse-deterrent pharmaceutical compositions for controlled release (2015-06-02),
12. 9023394 - Formulations and methods for the controlled release of active drug substances (2015-05-05),
13. 9005660 - Immediate release composition resistant to abuse by intake of alcohol (2015-04-14),
14. 8877241 - Morphine controlled release system (2014-11-04),
15. 8821928 - Controlled release pharmaceutical compositions for prolonged effect (2014-09-02),
Company Overview
Egalet Ltd. is a pharmaceutical company based in London, specializing in the development and commercialization of innovative pain management solutions. The organization focuses on creating advanced drug delivery systems that enhance therapeutic efficacy while minimizing the potential for abuse. With a commitment to addressing unmet medical needs, Egalet leverages its expertise in formulation science and technology to deliver products that improve patient outcomes in the field of pain management.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

22 Patents

#173 in London

#813 in United Kingdom

#28,749 in the World

London, GB
London, United Kingdom

Egalet Ltd.

Forward Citations = 221

24 inventors:

goldMedal Christine Andersen (11 out of 11 patents)

silverMedal Gina Engslev Fischer (11 out of 14 patents)

bronzeMedal Daniel K Bar-Shalom (11 out of 28 patents)

4.  Lillian Slot (9 out of 12 patents)

5.  Peter Holm Tygesen (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Egalet Ltd.. Retrieved from https://idiyas.com/company/egalet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…